Gilbert, J., Schell, M. J., Zhao, X., Murphy, B., Tanvetyanon, T., Leon, M. E., . . . Chung, C. H. (2015). A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma. Oral Oncol.
Styl cytowania ChicagoGilbert, Jill, et al. "A Randomized Phase II Efficacy and Correlative Studies of Cetuximab With or Without Sorafenib in Recurrent And/or Metastatic Head and Neck Squamous Cell Carcinoma." Oral Oncol 2015.
Styl cytowania MLAGilbert, Jill, et al. "A Randomized Phase II Efficacy and Correlative Studies of Cetuximab With or Without Sorafenib in Recurrent And/or Metastatic Head and Neck Squamous Cell Carcinoma." Oral Oncol 2015.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..